July 19, 2024
High End Cellomics

High End Cellomics Market is estimated to Witness High Growth Owing To Emerging Advancements in Imaging Technologies

The High End Cellomics Market is estimated to be valued at US$ 3.9 Bn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview: –

High end cellomics involves the use of advanced high throughput cell imaging techniques for applications in biology and medicine. High end cellomics provides non-invasive and quantitative information about cellular characteristics, phenotypes and cell-cell interactions. It enables scientists to study cells and cellular processes at an unprecedented scale, speed and resolution.

Market key trends: –

One of the key trends fuelling the growth of the high end cellomics market is the increasing adoption of advanced 3D and super-resolution imaging technologies. 3D imaging technologies are enabling researchers to capture spatial morphological information about cells in three dimensions. Super-resolution techniques like STORM and PALM allow capturing cell structures at nanoscale resolution beyond the diffraction limit. Another major trend is the development of artificial intelligence and machine learning integrated cellomics platforms. These automated platforms can analyze large sets of high content screening data more accurately and rapidly to identify meaningful patterns and insights. They are enhancing the productivity of drug discovery and translational research.

Porter’s Analysis: –

  • Threat of new entrants: – The high end cellomics market has moderately difficult barriers to entry due to high capital requirements for infrastructure development, advanced technologies needed and strong brand identity of established players.
  • Bargaining power of buyers: – The bargaining power of buyers is moderate due to the availability of substitute products and increasing consolidation among healthcare facilities and research institutes.
  • Bargaining power of suppliers: – A few global suppliers exist for different technologically advanced components used in cellomics instruments giving them a moderate bargaining power over manufacturers.
  • Threat of new substitutes: – The threat of substitutes is low as cellomics technique provides unique analysis at single cell level which cannot be replicated by other methods.
  • Competitive rivalry: – Intense due to presence of large global players continuously focusing on product innovation and service expansion.

SWOT Analysis: –

  • Strength: – Advanced cellomics instruments offering high throughput analysis and customized solution for research institutes. Growing R&D investment and expansions by key players.
  • Weakness: – High installation and maintenance cost of cellomics instruments limits adoption, especially in price sensitive areas. Requirement of skilled workforce for instrument operation.
  • Opportunity: – Increasing government funding for cellomics research and growing application in developing personalized medicine and tackling rare diseases. Emerging economies provide immense growth opportunities.
  • Threats: – Stringent approval process and heavy regulatory compliance requirement delay product commercialization. Threat from open-source sharing of cellomic protocols and techniques.

Key Takeaways: –

The Global High End Cellomics Market Growth is expected to witness high, exhibiting CAGR of 12% over the forecast period, due to increasing spending on healthcare infrastructure development and research activities globally. North America dominate the market with over 35% share in 2023 led by extensive R&D activities and presence of major players in the US.

The regional analysis shows Asia Pacific witnessing the fastest growth during the forecast period owing to increasing healthcare expenditure, rising awareness about personalized medicine and growth in pharmaceutical and biotechnology industries in major economies like China and India.

Key players operating in the high end cellomics market are Thermo Fisher Scientific, Danaher, PerkinElmer, BD, Bio-Rad Laboratories, Agilent Technologies, Illumina, Luminex, Merck KGaA, GE Healthcare, Bruker, Nanostring Technologies, 10x Genomics, Fluidigm, Celsee, Berkeley Lights, Miltenyi Biotec, Bionano Genomics, Bio-Techne, Sphere Fluidics. These players are focusing on new product launches and acquisition strategies to strengthen their market presence.

*Note:
1.  Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it